BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 20094097)

  • 1. [The effects of amiodarone on the thyroid].
    Toni M; Anda E; Pineda J; Martínez de Esteban JP; Ollero MD
    An Sist Sanit Navar; 2009; 32(3):363-70. PubMed ID: 20094097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan.
    Sato K; Miyakawa M; Eto M; Inaba T; Matsuda N; Shiga T; Ohnishi S; Kasanuki H
    Endocr J; 1999 Jun; 46(3):443-51. PubMed ID: 10503998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone-induced thyroid dysfunction in an iodine-replete area: epidemiological and clinical data.
    Zosin I; Balaş M
    Endokrynol Pol; 2012; 63(1):2-9. PubMed ID: 22378090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amiodarone and the thyroid gland].
    Bednarek-Tupikowska G; Filus A; Kuliczkowska J; Bugajski J
    Postepy Hig Med Dosw (Online); 2004 Apr; 58():216-25. PubMed ID: 15114257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and predictability of amiodarone-induced thyrotoxicosis and hypothyroidism.
    Hofmann A; Nawara C; Ofluoglu S; Holzmannhofer J; Strohmer B; Pirich C
    Wien Klin Wochenschr; 2008; 120(15-16):493-8. PubMed ID: 18820854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical value of regular thyroid function tests during amiodarone treatment.
    Benjamens S; Dullaart RPF; Sluiter WJ; Rienstra M; van Gelder IC; Links TP
    Eur J Endocrinol; 2017 Jul; 177(1):9-14. PubMed ID: 28424174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone-induced thyroid dysfunction.
    Danzi S; Klein I
    J Intensive Care Med; 2015 May; 30(4):179-85. PubMed ID: 24067547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency.
    Trifănescu R; Fica S; Barbu C; Vârtej I; Ursu H; Bunghez R; Coculescu M
    Rom J Intern Med; 2004; 42(3):595-605. PubMed ID: 16366133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amiodarone and thyroid dysfunction.
    Padmanabhan H
    South Med J; 2010 Sep; 103(9):922-30. PubMed ID: 20689491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
    Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of amiodarone-induced thyrotoxicosis and hypothyroidism].
    Gerber H; Noth D
    Ther Umsch; 1999 Jul; 56(7):374-9. PubMed ID: 10434774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone and the thyroid.
    Jabrocka-Hybel A; Bednarczuk T; Bartalena L; Pach D; Ruchała M; Kamiński G; Kostecka-Matyja M; Hubalewska-Dydejczyk A
    Endokrynol Pol; 2015; 66(2):176-86. PubMed ID: 25931048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Radiopharmaceuticals in Amiodarone-Induced Thyroid Pathology.
    Irimie A; Piciu D
    Curr Radiopharm; 2017 Nov; 10(3):146-154. PubMed ID: 28814251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approach to the patient with amiodarone-induced thyrotoxicosis.
    Bogazzi F; Bartalena L; Martino E
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2529-35. PubMed ID: 20525904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism.
    Trip MD; Wiersinga W; Plomp TA
    Am J Med; 1991 Nov; 91(5):507-11. PubMed ID: 1951413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey.
    Diehl LA; Romaldini JH; Graf H; Bartalena L; Martino E; Albino CC; Wiersinga WM
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):433-8. PubMed ID: 16984234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone-induced thyrotoxicosis. A review.
    Piga M; Serra A; Boi F; Tanda ML; Martino E; Mariotti S
    Minerva Endocrinol; 2008 Sep; 33(3):213-28. PubMed ID: 18846027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists.
    Tanda ML; Piantanida E; Lai A; Liparulo L; Sassi L; Bogazzi F; Wiersinga WM; Braverman LE; Martino E; Bartalena L
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):812-8. PubMed ID: 18410546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Amiodarone and thyroid disorders--prospective study and review of the literature].
    Vandergheynst F; Liénart F; Ducobu J
    Rev Med Brux; 1999 Oct; 20(5):411-7. PubMed ID: 10582476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic particularities in amiodarone induced thyroid disorder in patients with underlying cardiac condition.
    Costache L; Mogos V; Preda C; Vulpoi C; Ungureanu MC
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):959-64. PubMed ID: 25581954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.